Oppenheimer Asset Management Inc. Invests $211,000 in First Advantage Co. (NYSE:FA)

Oppenheimer Asset Management Inc. bought a new position in First Advantage Co. (NYSE:FA) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 13,127 shares of the company’s stock, valued at approximately $211,000.

Several other institutional investors have also made changes to their positions in the company. Price T Rowe Associates Inc. MD grew its position in First Advantage by 16.2% during the first quarter. Price T Rowe Associates Inc. MD now owns 15,478 shares of the company’s stock valued at $252,000 after purchasing an additional 2,163 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its position in First Advantage by 38.3% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 15,948 shares of the company’s stock valued at $256,000 after purchasing an additional 4,414 shares in the last quarter. Trium Capital LLP purchased a new position in First Advantage during the second quarter valued at approximately $324,000. MQS Management LLC purchased a new position in First Advantage during the first quarter valued at approximately $334,000. Finally, Paloma Partners Management Co purchased a new position in First Advantage during the first quarter valued at approximately $357,000. 94.91% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Separately, Truist Financial lowered their price objective on shares of First Advantage from $250.00 to $249.00 and set a “buy” rating on the stock in a research report on Monday, July 22nd. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, First Advantage currently has an average rating of “Moderate Buy” and a consensus price target of $96.00.

First Advantage Stock Performance

FA opened at $19.76 on Monday. The stock has a 50-day moving average of $18.00 and a 200-day moving average of $16.74. The company has a debt-to-equity ratio of 0.61, a quick ratio of 4.31 and a current ratio of 4.31. First Advantage Co. has a 52-week low of $12.46 and a 52-week high of $20.02. The company has a market cap of $2.87 billion, a PE ratio of 89.82, a price-to-earnings-growth ratio of 3.71 and a beta of 1.16.

First Advantage (NYSE:FA) last announced its quarterly earnings results on Thursday, August 8th. The company reported $0.21 EPS for the quarter, meeting the consensus estimate of $0.21. The company had revenue of $184.55 million for the quarter, compared to the consensus estimate of $184.66 million. First Advantage had a return on equity of 13.94% and a net margin of 3.24%. The company’s revenue for the quarter was down .4% compared to the same quarter last year. During the same quarter last year, the company posted $0.24 earnings per share. As a group, equities research analysts forecast that First Advantage Co. will post 0.82 earnings per share for the current fiscal year.

Insider Activity

In other First Advantage news, Director James Lindsey Clark sold 2,100 shares of First Advantage stock in a transaction that occurred on Wednesday, June 26th. The stock was sold at an average price of $15.48, for a total value of $32,508.00. Following the transaction, the director now directly owns 42,927 shares of the company’s stock, valued at approximately $664,509.96. The sale was disclosed in a document filed with the SEC, which is accessible through this link. 5.30% of the stock is currently owned by company insiders.

First Advantage Company Profile

First Advantage Corporation provides employment background screening, identity, and verification solutions worldwide. It offers pre-onboarding products and solutions, such as criminal background checks, drug/health screening, extended workforce screening, FBI channeling, identity checks and biometric fraud mitigation tools, education/work history verification, driver records and compliance, healthcare credentials, executive screening, and other screening products.